Time-series analysis: variation of anti-acetylcholine receptor antibody titer in myasthenia gravis is related to incidence of Mycoplasma pneumoniae and influenza virus infections. (1st February 2018)

• Record Type: Journal Article
• Authors: Iwasa, Kazuo; Yoshikawa, Hiroaki; Hamaguchi, Tsuyoshi; Sakai, Kenji; Shinohara-Noguchi, Moeko; Samuraki, Miharu; Takahashi, Kazuya; Yanase, Daisuke; Ono, Kenjiro; Ishida, Chiho; Yoshita, Mitsuhiro; Nakamura, Hiroyuki; Yamada, Masahito
• Is Part Of: Neurological research. Volume 40:Number 2(2018)
• Page Start: 102
• Page End: 109
• Publication Date: 2018-02-01
• Subjects: Myasthenia gravis -- anti-acetylcholine receptor antibody -- Mycoplasma pneumoniae -- influenza virus -- immune response; Neurology -- Periodicals; Neurosciences -- Periodicals; 616.8005
• DOI: 10.1080/01616412.2017.1407021
• Languages: English
• ISSNs: 0161-6412

Abstract

Abstract: Objectives: The exacerbating factors of myasthenia gravis (MG) are unknown. However, it has been speculated that infections may play a role in disease progression. Methods: We calculated the adjusted anti-acetylcholine receptor antibody (Adj-AChR-Ab) titers (range, 0–1) in 58 MG patients between 2006 and 2012. We determined the relationship between Adj-AChR-Ab titer and infection incidence. Results: A cross-correlation function (CCF) analysis of Adj-AChR-Ab titer and incidence of Mycoplasma pneumoniae ( M. pneumoniae ) ( r = 0.449, P < 0.0001) and influenza virus ( r = 0.411, P < 0.001) infections indicated significant correlations. MG with thymoma was highly correlated with M. pneumoniae infection ( r = 0.798, P < 0.0001). The relative risk for Adj-AChR-Ab titer was 1.407 for M. pneumoniae (95% CI, 1.193–1.661 for an increase in one infected patient per monitoring point) and 1.158 for influenza (95% CI, 1.071–1.253 for 100 infected patients). Conclusion: Variation of Adj-AChR-Ab titer is significantly influenced by the presence of M. pneumoniae and influenza virus infections.